Related Experiment Video
Updated: May 3, 2026

04:13
Using a Real-Time Locating System to Measure Walking Activity Associated with Wandering Behaviors Among Institutionalized Older Adults
Published on: February 8, 2019
5.9K
Missing link or not, mobilise against delirium
Critical Care (London, England)
|February 1, 2014
Summary
Postoperative delirium predicts poor outcomes and causes functional decline. Early patient mobilization in intensive care units (ICUs) is a priority to reduce delirium and improve recovery.
Area of Science:
- Critical Care Medicine
- Geriatric Medicine
- Neuroscience
Background:
- Delirium is a recognized predictor of adverse health outcomes.
- Postoperative delirium is linked to functional capacity decline after hospital discharge.
- Patients experiencing delirium often face lasting functional and cognitive impairments.
Purpose of the Study:
- To highlight the significance of delirium as a predictor of adverse outcomes.
- To emphasize the need for effective pharmacological treatments for delirium.
- To underscore the importance of early patient mobilization in intensive care settings.
Main Methods:
- A prospective study by Abelha and colleagues investigated postoperative delirium.
- The study identified delirium as an independent risk factor for functional deterioration.
- Evidence for early mobilization's impact on delirium and functional outcomes was reviewed.
Main Results:
- Postoperative delirium independently predicts functional capacity deterioration post-discharge.
- Delirium leads to new functional and cognitive impairments in patients.
- Early mobilization in ICUs decreases delirium incidence and enhances functional outcomes.
Conclusions:
- Pharmacological treatments for delirium prevention and management are a research priority.
- Early, progressive mobilization of all critically ill patients should be prioritized.
- Resources should be allocated to implement early mobilization strategies effectively.
Related Concept Videos
Dementia l: Introduction
35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35
Dementia
687
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
687
Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
REM Sleep Behavior Disorder
2.9K
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
2.9K
Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K

